SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aptus Pharma enters into Urology therapy segment

24 Nov 2025 Evaluate

Aptus Pharma has entered into the Urology therapy segment as part of its ongoing business expansion initiatives. The company will soon be launching a new portfolio of products in this segment, including Silodosin range, Tamsulosin range and Alkalizer formulations. 

The introduction of these products is supported by the company’s strong field-sales force and a robust distribution network consisting of 150+ PLS distributors and sub-distributors across India. This new portfolio is expected to contribute significantly to the company’s future revenue growth and profitability. 

Aptus Pharma is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the company does not own any manufacturing facilities, it operates through a contract manufacturing model.


Aptus Pharma Share Price

438.00 15.50 (3.67%)
06-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 223.40
Adani Enterprises 2539.40
Amrapali Industries 18.69
Rashi Peripheral 500.90
PDS 288.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×